Summary

Market Overview
The North America Cardiac Surgery Instruments Market was valued at USD 652.81 million in 2024 and is projected to reach USD 982.49 million by 2030, growing at a CAGR of 7.01% during the forecast period. The market is advancing steadily, propelled by demographic changes, a high incidence of cardiovascular diseases, and continuous innovation in surgical technologies. The United States and Canada dominate the regional landscape, contributing significantly to global cardiac surgical procedures and advanced medical device adoption.
An aging population and rising clinical complexity are intensifying the demand for surgical interventions, while favorable regulatory structures, strong institutional backing, and comprehensive reimbursement policies further drive adoption. Hospitals and healthcare providers are prioritizing investments in next-generation surgical instruments and infrastructure to accommodate increasingly complex cardiac procedures. As the trend moves toward precision and minimally invasive techniques, North America is poised to remain a key growth hub for the cardiac surgery instruments industry.
Key Market Drivers
Rising Prevalence of Cardiovascular Diseases (CVDs)
The increasing rate of cardiovascular disease across North America, particularly in the United States and Canada, is a major factor accelerating demand for cardiac surgeries and the associated instruments. In 2022, heart disease was the leading cause of death in the U.S., with 702,880 deaths—accounting for one in every five fatalities. Over 28 million U.S. adults were diagnosed with CVD by 2020, underscoring its widespread public health impact.
Common conditions such as coronary artery disease, heart failure, arrhythmias, and valvular disorders are becoming more prevalent due to risk factors like aging, sedentary behavior, diabetes, obesity, and hypertension. These rising health challenges necessitate advanced surgical interventions and drive demand for reliable, high-precision cardiac surgical instruments used in both traditional and minimally invasive procedures.
Key Market Challenges
High Cost of Cardiac Surgical Instruments and Associated Procedures
The high cost of acquiring and maintaining advanced cardiac surgical instruments remains a key challenge in the North America market. Many instruments, particularly those used in robotic and minimally invasive procedures, are crafted from specialized materials and must meet strict quality and regulatory standards—contributing to elevated costs.
Beyond the initial purchase, hospitals must also account for disposable accessories, complex instrument sets, and operating room expenses. When combined with pre- and post-operative care, the total cost of cardiac surgeries becomes prohibitive for underinsured or uninsured populations. These financial constraints may lead some facilities to limit their procurement or defer instrument upgrades, restricting market expansion.
Key Market Trends
Rising Demand for Minimally Invasive and Robotic-Assisted Cardiac Surgeries
A key trend shaping the North America cardiac surgery instruments market is the increasing adoption of minimally invasive and robot-assisted procedures. These surgical approaches offer benefits such as reduced blood loss, smaller incisions, faster recovery, and shorter hospital stays—driving their popularity among both patients and healthcare providers.
This trend is prompting hospitals to upgrade to specialized surgical tools compatible with minimally invasive and robotic platforms. In response, manufacturers are introducing smaller, precision-enhanced instruments and robotic-compatible systems. With platforms like the da Vinci system and upcoming innovations like the SSi Mantra gaining ground in cardiac surgery, demand for adaptable, high-performance instruments is expected to rise further.
Key Market Players
• BD
• B. Braun SE
• KLS Martin Group
• Teleflex Incorporated
• Medline Industries, LP
• STILLE Surgical Inc
• Surgical Holdings
• CONMED Corporation
• Cardinal Health
Report Scope:
In this report, the North America Cardiac Surgery Instruments Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• North America Cardiac Surgery Instruments Market, By Product:
 o Forceps
 o Clamps
 o Scalpels
 o Scissors
 o Needle Holders
 o Others
• North America Cardiac Surgery Instruments Market, By Application:
 o Coronary Artery Bypass Grafting
 o Heart Valve Surgery
 o Pediatric Surgery
 o Heart Transplant
 o Others
• North America Cardiac Surgery Instruments Market, By End User:
 o Hospitals
 o Ambulatory Surgical Centers
• North America Cardiac Surgery Instruments Market, By Country:
 o United States
 o Canada
 o Mexico
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the North America Cardiac Surgery Instruments Market.
Available Customizations:
North America Cardiac Surgery Instruments Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. North America Cardiac Surgery Instruments Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Forceps, Clamps, Scalpels, Scissors, Needle Holders, Others)
5.2.2. By Application (Coronary Artery Bypass Grafting, Heart Valve Surgery, Pediatric Surgery, Heart Transplant, Others)
5.2.3. By End User (Hospitals, Ambulatory Surgical Centers)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. United States Cardiac Surgery Instruments Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
7. Canada Cardiac Surgery Instruments Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
8. Mexico Cardiac Surgery Instruments Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Recent Developments
10.2. Product Launches
10.3. Mergers & Acquisitions
11. North America Cardiac Surgery Instruments Market: SWOT Analysis
12. Competitive Landscape
12.1. BD
12.1.1. Business Overview
12.1.2. Product & Service Offerings
12.1.3. Recent Developments
12.1.4. Key Personnel
12.1.5. Financials (If Listed)
12.1.6. SWOT Analysis
12.2. B. Braun SE
12.3. KLS Martin Group
12.4. Teleflex Incorporated
12.5. Medline Industries, LP
12.6. STILLE Surgical Inc
12.7. Surgical Holdings
12.8. CONMED Corporation
12.9. Cardinal Health
13. Strategic Recommendations
14. About Us & Disclaimer